Start

Annexin’s CEO: “The cancer area more than doubles the potential”

6 February, 2023

LS-klustret i Göteborg lyckat experiment

LS cluster in Gothenburg: a successful experiment

6 February, 2023

The CAR T revolution in the fight against cancer

2 February, 2023

Several biotech stocks was strong in January

Several biotech stocks surging during strong January

1 February, 2023

Prolevi Bio's CEO Sahil Gupta in BioStock's studio

Prolevi Bio on the financing round and focus for 2023

31 January, 2023

STUDIO

Prolevi Bio on the financing round and focus for 2023

31 January, 2023

Privately held Prolevi Bio aims improve treatment for many patients suffering from hypoterosis. The company has developed a method that is to improve the drug...

Prolevi Bios vd Sahil Gupta på Medicon Village

BioStock Investor Pitch: Prolevi Bio

27 January, 2023

BioStock Investor Pitch: Spermosens

16 January, 2023

Alligator Bioscience presents positive interim data

3 January, 2023

Cyxone’s CEO on the current state and the pipeline

14 December, 2022

Annexin’s CEO: “The cancer area more than doubles the potential”

6 February, 2023

Annexin Pharmaceuticals' candidate ANXV is being developed as a new treatment for retinal vein...

LS cluster in Gothenburg: a successful experiment

6 February, 2023

Life Science is an important sector for western Sweden's business community, and the life...

The CAR T revolution in the fight against cancer

2 February, 2023

Several biotech stocks surging during strong January

1 February, 2023

Prolevi Bio on the financing round and focus for 2023

31 January, 2023

BioStock Investor Pitch: Prolevi Bio

27 January, 2023

EVENT

BioStock Life Science Fall Summit Mingle interviews

Watch interviews from BioStock Life Science Fall Summit

13 December, 2022

BioStock Investor Meeting, September 14

15 August, 2022

BioStock life science spring summit 2022

BioStock Life Science Spring Summit, June 8-9, 2022

26 March, 2022

BioStock Investor Meeting 16 March

16 March, 2022

BioStock News @biostock_news ·

23 Jan

Ultimovacs Announces Completed Patient Recruitment in NIPU Phase II Clinical Trial of UV1 in Mesothelioma
https://www.globenewswire.com/news-release/2023/01/23/2592873/0/en/Ultimovacs-Announces-Completed-Patient-Recruitment-in-NIPU-Phase-II-Clinical-Trial-of-UV1-in-Mesothelioma.html
#BioStockSwe #lifescience @ultimovacs

Reply on Twitter 1617454314385211392 Retweet on Twitter 1617454314385211392 Like on Twitter 1617454314385211392 2 Twitter 1617454314385211392

BioStock News @biostock_news ·

13 Dec

Mendus presents proof-of-concept data in AML maintenance
https://www.biostock.se/en/2022/12/mendus-presenterar-proof-of-concept-data-for-underhall-av-aml/
#BioStockSwe #lifescience @mendus_ab

Reply on Twitter 1602577051072045056 Retweet on Twitter 1602577051072045056 Like on Twitter 1602577051072045056 Twitter 1602577051072045056

BioStock News @biostock_news ·

13 Dec

The innovative force behind Ultimovacs' cancer vaccine
https://www.biostock.se/en/2022/12/den-innovativa-kraften-bakom-ultimovacs-cancervaccin/
#BioStockSwe #lifescience @ultimovacs

Reply on Twitter 1602576486569050113 Retweet on Twitter 1602576486569050113 Like on Twitter 1602576486569050113 4 Twitter 1602576486569050113

Ladda fler

STUDIO

RECOMMENDED READING

EVENT